High-flying, unprofitable pure-play quantum computing stocks will likely plunge if the bubble bursts. Tech giants that are ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the most oversold biotech stocks to invest in. Following the company’s third-quarter financial results, Oppenheimer reaffirmed its Outperform rating ...

Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...

Berkshire Hathaway (BRK.B) recently added Alphabet to its portfolio. Alphabet’s valuation is the best among its Magnificent 7 peers. Alphabet reported 16% revenue growth driven by 33% gains in both ...